Akèy › Maladi otoim › Connecticut › New Haven
Etid klinik pou Maladi otoim nan New Haven, CT
5 etid pou Maladi otoim ap chèche patisipan nan sit nan ak bò kote New Haven (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Ap rekriteFaz 2/3
- Yale University, New Haven
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Ap rekriteFaz 3
- Site Number - 1001, New Haven
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- Yale New Haven Hospital, New Haven
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Ap rekriteFaz 1/2
- Yale University, New Haven
Etid Maladi otoim nan lòt vil
- Houston, TX21 etid
- Washington, DC19 etid
- New York City, NY19 etid
- Philadelphia, PA16 etid
- Durham, NC15 etid
- Boston, MA13 etid
- Los Angeles, CA12 etid
- Chicago, IL12 etid
- Dallas, TX9 etid
- Cleveland, OH8 etid
- Milwaukee, WI8 etid
- Atlanta, GA8 etid
Lòt etid nan New Haven
- Kansè Poumon ki pa ti selil41 etid
- Kansè nan tete37 etid
- Kansè (tout kalite)33 etid
- Kansè Metastatik23 etid
- Kansè poumon22 etid
- Karsinòm selil skuamèz tèt ak kou22 etid
- Kansè ovè21 etid
- Kansè kolorektal20 etid
- Kansè pwostat20 etid
- Sòvdòz Opioyid18 etid
- Twoub Konsomasyon Alkòl (AUD)17 etid
- Leksemi mieloïd egi17 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.